XML 42 R29.htm IDEA: XBRL DOCUMENT
v3.22.1

Licensed rights and other intangible assets (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2021
Goodwill And Intangible Assets Disclosure [Abstract] |
Summary of Information about License Rights and Other Intangible Assets, Net | The following provides information about our license rights and other intangible assets, net (in thousands):
|  | As of December 31, 2021 |  |  | As of December 31, 2020 |
|  | Gross |  |  |  |  |  |  |  |  |  |  | Gross |  |  |  |  |  |  |  |  |
|  | Carrying |  |  | Accumulated |  |  |  |  |  |  | Carrying |  |  | Accumulated |  |  |  |  |
|  | Amount |  |  | Amortization |  |  | Net |  |  | Amount |  |  | Amortization |  |  | Net |
License rights and other intangible assets subject to amortization: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
License rights |  | $ | 40,000 |  |  | $ | 6,826 |  |  | $ | 33,174 |  |  | $ | 40,000 |  |  | $ | 3,803 |  |  | $ | 36,197 |
Hormone therapy drug patents |  |  | 5,834 |  |  |  | 1,042 |  |  |  | 4,792 |  |  |  | 4,045 |  |  |  | 749 |  |  |  | 3,296 |
Hormone therapy drug patents applied and pending approval |  |  | 2,020 |  |  |  | — |  |  |  | 2,020 |  |  |  | 1,629 |  |  |  | — |  |  |  | 1,629 |
License rights and other intangible assets subject to amortization |  |  | 47,854 |  |  |  | 7,868 |  |  |  | 39,986 |  |  |  | 45,674 |  |  |  | 4,552 |  |  |  | 41,122 |
Intangible assets not subject to amortization: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Trademarks/trade name rights |  |  | 332 |  |  |  | — |  |  |  | 332 |  |  |  | 323 |  |  |  | — |  |  |  | 323 |
License rights and other intangible assets, net |  | $ | 48,186 |  |  | $ | 7,868 |  |  | $ | 40,318 |  |  | $ | 45,997 |  |  | $ | 4,552 |  |  | $ | 41,445 |
Summary of License Rights And Other Intangible Assets Subject To Amortization Is Expected To Be Amortized | Our license rights and other intangible assets subject to amortization is expected to be amortized as follows (in thousands):
Year ending December 31, |
2022 |  | $ | 3,451 |
2023 |  |  | 3,445 |
2024 |  |  | 3,447 |
2025 |  |  | 3,445 |
2026 |  |  | 3,445 |
Thereafter |  |  | 20,733 |
Total |  | $ | 37,966 |

X
- Definition Tabular disclosure of amortization expense of assets, excluding financial assets, that lack physical substance, having a limited useful life. + References No definition available. + Details
Name: | us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 2 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275 + Details
Name: | us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration